{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:27:52Z","timestamp":1780316872623,"version":"3.54.1"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Inhaled anticholinergics are commonly used in chronic respiratory diseases with the intention of reducing bronchial secretions in addition to their bronchodilatory effects. However, evidence regarding their direct influence on mucus production and clearance remains limited and fragmented. This study aimed to identify, evaluate, and synthesize the available evidence on the effects of inhaled and nebulized anticholinergics on mucus volume, rheological properties, mucociliary clearance, cough, and pulmonary function in adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review was conducted following PRISMA 2020 guidelines and registered in PROSPERO (CRD42024575999). Comprehensive searches were performed in PubMed, OVID, Embase, SciELO, EBSCO, ScienceDirect, and Cochrane Library without date restrictions. Randomized and non-randomized studies assessing inhaled or nebulized anticholinergics were included. Risk of bias was evaluated using the RoB 2 and ROBINS-I tools.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Out of 2,449 records identified, eight studies comprising 403 participants met the inclusion criteria. Under stable clinical conditions, inhaled ipratropium and tiotropium showed no significant changes in sputum volume, viscosity, or mucociliary clearance compared with placebo. In acute or procedural settings, such as bronchoscopy, nebulized ipratropium was associated with a reduction in bronchial secretion grade and cough frequency. Tiotropium treatment demonstrated decreases in sputum solid fraction and mucin content (MUC5AC and MUC5B). None of the included studies reported impairment of mucociliary clearance or serious adverse events related to treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Current evidence does not demonstrate a consistent effect of inhaled or nebulized anticholinergics on sustained reduction of bronchial secretions. However, their use does not appear to cause adverse changes in mucus production or clearance and may induce transient effects during acute cholinergic stimulation. Overall, the findings support a favorable safety profile of these agents regarding airway secretion management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/<\/jats:ext-link>\n                      , identifier CRD42024575999.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphys.2026.1790151","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T04:21:38Z","timestamp":1776140498000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of inhaled anticholinergics on bronchial secretions: a systematic review"],"prefix":"10.3389","volume":"17","author":[{"given":"Leonardo","family":"Arzayus-Pati\u00f1o","sequence":"first","affiliation":[{"name":"Facultad de Salud, Programa de Fisioterapia, Universidad Santiago de Cali","place":["Cali, Colombia"]},{"name":"Grupo de Investigaci\u00f3n Salud y Movimiento, Universidad Santiago de Cali","place":["Cali, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Juli\u00e1n","family":"Bernal-Sanchez","sequence":"additional","affiliation":[{"name":"Facultad de Salud, Programa de Fisioterapia, Universidad Santiago de Cali","place":["Cali, Colombia"]},{"name":"Grupo de Investigaci\u00f3n Salud y Movimiento, Universidad Santiago de Cali","place":["Cali, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"P\u00e9rez-Hortua","sequence":"additional","affiliation":[{"name":"Facultad de Salud, Escuela de Rehabilitaci\u00f3n Humana","place":["Cali, Colombia"]},{"name":"Grupo de Investigaci\u00f3n Ejercicio y Salud Cardiopulmonar (GIESC)","place":["Cali, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther Cecilia","family":"Wilches-Luna","sequence":"additional","affiliation":[{"name":"Facultad de Salud, Escuela de Rehabilitaci\u00f3n Humana","place":["Cali, Colombia"]},{"name":"Grupo de Investigaci\u00f3n Ejercicio y Salud Cardiopulmonar (GIESC)","place":["Cali, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Benavides-Cordoba","sequence":"additional","affiliation":[{"name":"Facultad de Salud, Departamento de Ciencias Fisiol\u00f3gicas, Universidad del Valle","place":["Cali, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1111\/j.1464-410X.2010.09600.x","article-title":"Inhaled anticholinergic drugs and risk of acute urinary retention","volume":"107","author":"Afonso","year":"2011","journal-title":"BJU Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/2040622313518227","article-title":"Long-acting muscarinic receptor antagonists for the treatment of chronic\u00a0airway diseases","volume":"5","author":"Alagha","year":"2014","journal-title":"Ther. Adv. Chronic. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1183\/09059180.00003510","article-title":"Mucoactive drugs","volume":"19","author":"Balsamo","year":"2010","journal-title":"Eur. Respir. Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"63S","DOI":"10.1378\/chest.117.2_suppl.63S","article-title":"The pharmacological properties of tiotropium","volume":"117","author":"Barnes","year":"2000","journal-title":"Chest"},{"key":"B5","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1517\/13543784.10.4.733","article-title":"Tiotropium bromide","volume":"10","author":"Barnes","year":"2001","journal-title":"Expert Opin. Invest. Drugs"},{"key":"B6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1513\/pats.200504-043SR","article-title":"Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease","volume":"2","author":"Belmonte","year":"2005","journal-title":"Proc. Am. Thorac. Soc."},{"key":"B7","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1378\/chest.103.2.488","article-title":"The acute effect of ipratropium bromide bronchodilator therapy on cough clearance in COPD","volume":"103","author":"Bennett","year":"1993","journal-title":"Chest"},{"key":"B8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/978-3-642-23274-9_14","article-title":"Muscarinic receptor antagonists: Effects on pulmonary function","volume-title":"Muscarinic receptors","author":"Buels","year":"2012"},{"key":"B9","doi-asserted-by":"publisher","first-page":"210196","DOI":"10.1183\/16000617.0196-2021","article-title":"The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review","volume":"31","author":"Calzetta","year":"2022","journal-title":"Eur. Respir. Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1152\/japplphysiol.00313.2006","article-title":"Reflex regulation of airway smooth muscle tone","volume":"101","author":"Canning","year":"2006","journal-title":"J. Appl. Physiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1056\/NEJMra0910061","article-title":"Airway mucus function and dysfunction","volume":"363","author":"Fahy","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1128\/AAC.32.11.1644","article-title":"Ipratropium bromide treatment of experimental rhinovirus infection","volume":"32","author":"Gaffey","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1701247","DOI":"10.1183\/13993003.01247-2017","article-title":"The mode of action of anticholinergics in asthma","volume":"52","author":"Gosens","year":"2018","journal-title":"Eur. Respir. J."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-7-73","article-title":"Muscarinic receptor signaling in the pathophysiology of asthma and COPD","volume":"7","author":"Gosens","year":"2006","journal-title":"Respir. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1378\/chest.125.5.1726","article-title":"The effect of inhaled tiotropium bromide on lung mucociliary clearance in patients with COPD","volume":"125","author":"Hasani","year":"2004","journal-title":"Chest"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2147\/copd.s4620","article-title":"A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD","volume":"4","author":"Hilleman","year":"2009","journal-title":"Int\u00a0J Chron Obstruct Pulmon Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ejpb.2023.12.001","article-title":"Mucoactive drugs and multiple applications in pulmonary disease therapy","volume":"194","author":"Hocquigny","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"B18","doi-asserted-by":"publisher","first-page":"6314","DOI":"10.21037\/jtd.2018.09.153","article-title":"Clinical practice guidelines for diagnosis and management of cough\u2014Chinese Thoracic Society (CTS) Asthma Consortium","volume":"10","author":"Lai","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"B19","volume-title":"Pulmonary and critical care pharmacology and therapeutics","author":"Leff","year":"1996"},{"key":"B20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0021-5198(19)40132-7","article-title":"Effects of anticholinergic bronchodilators on mucociliary transport and airway secretion","volume":"51","author":"Miyata","year":"1989","journal-title":"Jpn.\u00a0J. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.36497\/jri.v43i4.256","article-title":"The effect of inhaled ipratropium bromide as a premedication for bronchoscopy on dyspnea, cough, and tracheobronchial secretion","volume":"43","author":"Mutmainnah","year":"2023","journal-title":"J. Respirol. Indones."},{"key":"B22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejim.2021.01.027","article-title":"Inhaled long-acting muscarinic antagonists in asthma \u2013 a narrative review","volume":"85","author":"Papi","year":"2021","journal-title":"Eur. J. Internal Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1136\/thx.34.4.501","article-title":"Effect of ipratropium bromide on mucociliary clearance and pulmonary function in reversible airways obstruction","volume":"34","author":"Pavia","year":"1979","journal-title":"Thorax"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S38938","article-title":"Clinical issues of mucus accumulation in COPD","volume":"9","author":"Ramos","year":"2014","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.125.1.101","article-title":"Effects of mucokinetic drugs on rheological properties of reconstituted human nasal mucus","volume":"125","author":"Rhee","year":"1999","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"B26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.coph.2004.01.011","article-title":"Airway mucus hypersecretion in asthma: an undervalued pathology","volume":"4","author":"Rogers","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.4187\/respcare.07521176","article-title":"Mucoactive agents for airway mucus hypersecretory diseases","volume":"52","author":"Rogers","year":"2007","journal-title":"Respir. Care"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2147\/DHPS.S7771","article-title":"Safety and tolerability of inhalational anticholinergics in COPD","volume":"5","author":"Sharafkhaneh","year":"2013","journal-title":"Drug Healthc Patient Saf."},{"key":"B29","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"B30","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"B31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.pupt.2016.06.008","article-title":"Effect of tiotropium on mucus hypersecretion and airway clearance in patients with COPD","volume":"39","author":"Tagaya","year":"2016","journal-title":"Pulm. Pharmacol. Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","article-title":"A 4-year trial of tiotropium in chronic obstructive pulmonary disease","volume":"359","author":"Tashkin","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/thx.41.4.295","article-title":"Effect of four weeks\u2019 high dose ipratropium bromide treatment on lung mucociliary clearance","volume":"41","author":"Taylor","year":"1986","journal-title":"Thorax"},{"key":"B34","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.jaci.2010.05.046","article-title":"Ciliary dysfunction and ultrastructural abnormalities are features of severe asthma","volume":"126","author":"Thomas","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1165\/rcmb.2009-0304OC","article-title":"Goblet cells are derived from a FOXJ1 -expressing progenitor in a human airway epithelium","volume":"44","author":"Turner","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017942","article-title":"Nebulized ipratropium bromide protects against tracheal and bronchial secretion during bronchoscopy: a randomized controlled trial","volume":"98","author":"Wang","year":"2019","journal-title":"Medicine"}],"updated-by":[{"DOI":"10.3389\/fphys.2026.1883894","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000}}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2026.1790151\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T12:55:59Z","timestamp":1779800159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2026.1790151\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":36,"alternative-id":["10.3389\/fphys.2026.1790151"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2026.1790151","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"article-number":"1790151"}}